PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company\u2019s original seed investor.
Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of \u00a33M have been announced today*. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.
European Research Council grants worth more than \u20ac16.3 million have today been awarded to eight University of Oxford researchers for a range of cutting-edge projects.
The University of Oxford team who have developed a COVID-19 vaccine in record time have been shortlisted for the Excellence in Healthcare Award at the NHS Parliamentary Awards.
Toluwalase Awoyemi, DPhil student in Nuffield Department of Women's & Reproductive Health, is recognised with an Africa 35.35 Award - a celebration of the top 35 leading young changemakers under 35 in Africa in 2020.
Magda Mare\u010dkov\u00e1, Nuffield Department of Women's & Reproductive Health DPhil student, has won this year's special prize, the Special Young Scientist Award at the Fast Forward Science 2020 web-video competition. She wins for her compelling video: \"Heavy periods, sharp pain and no one to listen to you? Could you have Endometriosis?\".
Dr Gurdeep Mannu from the Nuffield Department of Population Health has won the Office for National Statistics (ONS) Research Excellence Award for a study which highlighted early risk factors for breast cancer patients.
Bvlgari and the University of Oxford\u2019s Jenner Institute announce the next stage of their pledge to build a pandemic-free future by awarding the inaugural Bvlgari Scholarships.
Members of the University have been recognised in the 2020 Queen's Birthday Honours List, including scientists from across the Medical Sciences Division.
Professor Paul Riley will lead the scientific vision of the first institute of its kind in the world to physically merge the disciplines of developmental biology and regenerative medicine in a common goal to treat some of the world\u2019s most prolific diseases.
Every year, the British Medical Journal (BMJ) runs a competition to find the cancer care team that has developed new approaches to improve cancer diagnosis and treatment. This year, six teams were shortlisted from across the UK and on the 7th October it was announced that the Oxfordshire-based SCAN pathway had won this year\u2019s award.
The awardees for the second round of the University of Oxford\u2019s Enriching Engagement funding scheme have now been announced, including six projects from across the Medical Sciences Division.
The NIHR Oxford Biomedical Research Centre (BRC) has received more than \u20ac270,000 from the European Commission as a part of a multi-nation research project to promote citizen science.
Professor David Stuart has been awarded The Gabor Medal 2020 for his seminal contributions to understanding virus structure and application to vaccine design, as well as driving the application of engineering and physical science to the life sciences.
There is an increasing body of genetic and biochemical evidence that points toward lysosomal dysfunction as a risk factor for developing age-related neurodegenerative disorders, including Parkinson\u2019s disease (PD).
![\"Necrotic](\"https://www.medsci.ox.ac.uk/news/university-spinout-pepgen-awarded-major-financing-to-target-duchenne-muscular-dystrophy/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n